C2Dx Acquires STIC Intra-Compartmental Pressure Monitoring System from Stryker Corporation
June 28, 2019
Kalamazoo, MI, June 28, 2019 –(PR.com)– Critical Care Diagnostics (C2Dx) Inc., a medical device company focused on providing solutions for the unplanned, life-threatening medical needs of patients and healthcare providers, has been formed to provide medical professionals with a comprehensive range of products.
The C2Dx initial product line was acquired from Stryker, one of the world’s leading medical technology companies. The Intra-Compartmental Pressure Monitor, also known as the STIC Monitor is considered the gold standard worldwide for diagnosing and managing acute and chronic compartment syndrome. This condition is associated with severe injuries arising from auto accidents, active sports, workplace occurrences, and battlefield injuries to name a few.
C2Dx was founded by Kevin McLeod and Plymouth Growth Partners, an Ann Arbor, Michigan based growth capital firm. The business is based in Schoolcraft, Michigan just miles from the original birthplace of the STIC Monitor product line. Kevin McLeod commented, “Our leadership team has extensive experience leading all phases of a Medical Device manufacturer. Acute and chronic compartment syndrome has been receiving renewed attention as the population ages and people are determined to stay active into their later years of life. Timely diagnosis and intervention can avoid unnecessary and expensive procedures. We are excited to bring together extensive regional resources to pursue C2Dx’s mission.”